Population‐based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Arthritis care & research

• Publication date

  2011-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/acr.20408PMID 21452267
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence of spondyloarthritis and its subtypes in southern Sweden

  2011cited by this paper
• Antibodies to human tissue transglutaminase and alterations of vitamin D metabolism in ankylosing spondylitis and psoriatic arthritis

  2010cited by this paper
• Prevalence and incidence of rheumatoid arthritis in southern Sweden 2008 and their relation to prescribed biologics.

  2010cited by this paper
• Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population-based study

  2010cited by this paper
• Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies

  2010cited by this paper
• Developments in the scientific and clinical understanding of the spondyloarthritides

  2009cited by this paper
• Interpreting registry-derived drug studies: does societal context matter?

  2009cited by this paper
• Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis.

  2009cited by this paper
• The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort.

  2009cited by this paper
• Spondyloarthritis Is Associated with Poor Function and Physical Health-Related Quality of Life

  2009cited by this paper
• The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

  2009cited by this paper
• Ankylosing spondylitis: a risk factor for myocardial infarction?

  2009influential reference
• Epidemiology of ankylosing spondylitis.

  2008cited by this paper
• Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review

  2007cited by this paper
• Cardiovascular risk in inflammatory rheumatic diseases: loose ends and common threads.

  2006cited by this paper
• Identification of the most common problems by patients with ankylosing spondylitis using the international classification of functioning, disability and health.

  2006cited by this paper
• Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

  2006influential reference
• Incidence and prevalence of ankylosing spondylitis in Northern Norway.

  2005cited by this paper
• Making an impact on mortality in rheumatoid arthritis: targeting cardiovascular comorbidity.

  2004cited by this paper
• Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.

  2004cited by this paper
• Health status of patients with ankylosing spondylitis: a comparison with the general population

  2004cited by this paper
• Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-α therapy and other novel approaches

  2002cited by this paper
• Ankylosing spondylitis: an overview

  2002cited by this paper
• Incidence and prevalence of ankylosing spondylitis in Finland.

  1997cited by this paper
• Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis.

  1993cited by this paper
• Statistical Methods in Cancer Research, Vol. 2, the Design and Analysis of Cohort Studies

  1990cited by this paper
• Survival among patients with ankylosing spondylitis: a life-table analysis.

  1981cited by this paper
• Epidemiology of Ankylosing spondylitis in Rochester, Minnesota, 1935-1973.

  1979cited by this paper
• International Agency for Research on Cancer.

  1968cited by this paper

• Vascular effects of achieving low disease activity in axial spondyloarthritis - A 2-year prospective treat-to-target study.

  2026cites this paper
• Known and less well-known comorbidities in axial spondyloarthritis: what are we overlooking? Results from the SPARTAKUS cohort

  2025cites this paper
• Causal link between ankylosing spondylitis and thyroid dysfunction: A Mendelian randomization study

  2025cites this paper
• The significance of insufficiency fractures in rheumatic musculoskeletal diseases

  2025cites this paper
• Risk of cardiovascular disease associated with use of tumor necrosis factor inhibitors in ankylosing spondylitis

  2025cites this paper
• The Role of Aminopeptidase ERAP1 in Human Pathology—A Review

  2024influential citation
• Risk of cardiovascular disease decreases over time in psoriatic arthritis but not in spondylarthritis: meta-analysis of longitudinal studies.

  2024cites this paper
• Effects of ankylosing spondylitis on cardiovascular disease: aMendelian randomization study

  2024cites this paper
• Relationship Between Ankylosing Spondylitis and Cerebrovascular Disorders: A Systematic Review

  2024influential citation
• Some features of osteogenesis in ankylosing spondylitis and the possibilities of treatment with bisphosphonates

  2024cites this paper
• Diabetes in axial spondyloarthritis: a systematic review and meta-analysis of observational studies

  2024cites this paper
• Independent Relationship between Ankylosing Spondylitis and Presystolic Wave Detected on Echocardiography

  2024cites this paper
• Thyroid disease in ANCA-associated vasculitis: a clinical and epidemiological study

  2024cites this paper
• The association of TNF inhibitor use with incident cardiovascular events in radiographic axial spondyloarthritis.

  2024cites this paper
• Risk of cardiovascular disease associated with long-term use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis.

  2024cites this paper
• Cardiovascular disease in spondyloarthritis: a narrative review of risk factors and the effect of treatments

  2023cites this paper
• Obesity Represents a Persisting Health Issue in Axial Spondyloarthritis, Particularly Affecting Socially Disadvantaged Patients

  2023cites this paper
• No evidence of a causal relationship between ankylosing spondylitis and cardiovascular disease: a two-sample Mendelian randomization study

  2023cites this paper
• Inflammation is associated with incident hypertension in patients with axial spondyloarthritis: A longitudinal cohort study

  2023cites this paper
• [Immune-mediated inflammatory diseases in Germany : A cross-sectional analysis of comorbidities and pharmacotherapy].

  2023cites this paper
• Effect of neridronate on axial involvement in patients with spondyloarthritis when biologics are not possible. Results of a monocentric study

  2023cites this paper
• Occurrence and relative risks for non-vertebral fractures in patients with ankylosing spondylitis compared with the general population: a register-based study from Sweden

  2023cites this paper
• Pakistani Ankylosing Spondylitis Cohort with modifiable cardiovascular risk factors (PAS-CVD) study

  2023cites this paper
• Ankylosing spondylitis substantially increases health-care costs and length of hospital stay following total hip arthroplasty - National in-patient database study.

  2023cites this paper
• Impact of ankylosing spondylitis on stroke limited to specific subtypes: Evidence from Mendelian randomization study

  2023cites this paper
• A combination of two or more unhealthy lifestyle factors is associated with impaired physical and mental health in patients with spondyloarthritis: a cross-sectional study

  2022cites this paper
• Cardiovascular Morbidity in Ankylosing Spondylitis: A Focus on Inflammatory Cardiac Disease

  2022cites this paper
• A Statewide Study of Cardiovascular Outcomes in Patients with Ankylosing Spondylitis

  2022cites this paper
• Uveitis as a Risk Factor for Developing Acute Myocardial Infarction in Ankylosing Spondylitis: A National Population-Based Longitudinal Cohort Study

  2022cites this paper
• High Prevalence of Previously Undiagnosed Axial Spondyloarthritis in Patients Referred With Anterior Uveitis and Chronic Back Pain: The SpEYE Study

  2022cites this paper
• Association and Risk of Axial Spondyloarthritis of Scoliosis Patients

  2021cites this paper
• The Association of Tumor Necrosis Factor Inhibitor Use With Incident Hypertension in Ankylosing Spondylitis: Data From the PSOAS Cohort

  2021cites this paper
• A cross-sectional study on clinical characteristics of Saudi axial spondylarthritis: preliminary results.

  2021cites this paper
• Relationship Between Body Mass Index, Disease Activity, and Exercise in Ankylosing Spondylitis

  2021cites this paper
• Distribution of comorbidities in spondyloarthritis with regard to the phenotype and psoriasis: data from the ASAS-COMOSPA study

  2021cites this paper
• Test-Retest Reliability and Validity of the Six Minute Stepper Test to Evaluate Functional Exercise Capacity in Patients with Ankylosing Spondylitis.

  2021cites this paper
• Impact of the number of comorbidities on the outcome measures and on the retention rate of the first anti-TNF in patients with Ankylosing Spondylitis. Two-year follow-up in REGISPONSER-AS.

  2021cites this paper
• Association of methylation level and transcript level in TRAF5 gene with ankylosing spondylitis: a case-control study

  2021influential citation
• TCM nonpharmacological interventions for ankylosing spondylitis

  2021cites this paper
• Physical activity in people with axial spondyloarthritis and the impact of overall attitudes, barriers, and facilitators: A cross-sectional study.

  2020cites this paper
• Associations between fucosyltransferase 3 gene polymorphisms and ankylosing spondylitis: A case–control study of an east Chinese population

  2020cites this paper
• Cardiovascular Risk Scores in Axial Spondyloarthritis Versus the General Population: A Cross-sectional Study

  2020cites this paper
• An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica

  2020cites this paper
• Prevalence and pattern of comorbidities in chronic rheumatic and musculoskeletal diseases: the COMORD study

  2020cites this paper
• Impact of tumor necrosis factor inhibitors and methotrexate on diabetes mellitus among patients with inflammatory arthritis

  2020cites this paper
• Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross‐Sectional Study

  2020cites this paper
• Biomechanical Properties of Common Carotid Arteries Assessed by Circumferential 2D Strain and β Stiffness Index in Patients With Ankylosing Spondylitis

  2020cites this paper
• Association of body mass index on disease activity in axial spondyloarthritis: systematic review and meta-analysis

  2020cites this paper
• Infections Are Associated With Increased Risk of Giant Cell Arteritis: A Population-based Case-control Study from Southern Sweden

  2020cites this paper
• Evaluation of the impact of a nurse-led program of systematic screening of comorbidities in patients with axial spondyloarthritis: The results of the COMEDSPA prospective, controlled, one year randomized trial.

  2020cites this paper
• Nonsteroidal Antiinflammatory Drug Use and Association With Incident Hypertension in Ankylosing Spondylitis

  2020cites this paper
• Differences between diffuse idiopathic skeletal hyperostosis and spondyloarthritis.

  2020cites this paper
• Patient-Reported Outcomes Following Inpatient Multimodal Treatment Approach in Chronic Pain-Related Rheumatic Diseases

  2020cites this paper
• Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis

  2020cites this paper
• A protocol for systematic review and network meta-analysis

  2020cites this paper
• Update of imaging in the diagnosis and management of axial spondyloarthritis.

  2020cites this paper
• Perioperative Care of the Orthopedic Patient with Connective Tissue Disease

  2020cites this paper
• The Efficacy and Safety of Simple-Needling Therapy for Treating Ankylosing Spondylitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2020cites this paper
• OP-BRHE200248 47..57

  2020cites this paper
• The impact of sex and disease classification on patient-reported outcome measures in axial spondyloarthritis: a descriptive prospective cross-sectional study

  2019cites this paper
• Relationship between Ankylosing Spondylitis and Obstructive Sleep Apnea Syndrome with Epworth Sleepiness Scale and Müller Maneuver

  2019cites this paper
• The prevalence of comorbidity and predictors in ankylosing spondylitis.

  2019cites this paper
• Nonsteroidal Anti-inflammatory Drug use is Associated with Incident Hypertension in Ankylosing Spondylitis

  2019cites this paper
• Nonsteroidal Anti-inflammatory Drug use is Associated with Incident Hypertension in Ankylosing Spondylitis

  2019cites this paper
• The Diabetes, Depression, and Alcohol Triad

  2019cites this paper
• Cardiovascular risk in ankylosing spondylitis and the effect of anti-TNF drugs: a narrative review

  2019cites this paper
• Burden of severe spondyloarthritis in France: A nationwide assessment of prevalence, associated comorbidities and cost.

  2019cites this paper
• Le fardeau des spondyloarthrites graves en France : évaluation de la prévalence, des comorbidités et des coûts à l’échelle nationale

  2019cites this paper
• Cardiovascular Disease in Spondyloarthritides

  2019cites this paper
• Epicardial adipose tissue thickness is associated with disease severity in patients with newly- diagnosed ankylosing spondylitis.

  2019cites this paper
• Multimorbidity in Axial Spondyloarthropathy and Its Association with Disease Outcomes: Results from the Ankylosing Spondylitis Registry of Ireland Cohort

  2019cites this paper
• The correlation between intestinal dysbiosis and the development of ankylosing spondylitis.

  2019cites this paper
• Insight into the Quality of Life of Patients with Ankylosing Spondylitis: Real-World Data from a US-Based Life Impact Survey

  2019cites this paper
• Ankylosing spondylitis and mesenchymal stromal/stem cell therapy: a new therapeutic approach.

  2019cites this paper
• Endothelial dysfunction in patients with ankylosing spondylitis

  2019cites this paper
• Full Prevalence of comorbidities and risk factors of for comorbidities in patients with spondyloarthritis in Latin America: a comparative study with the general population and data from the multinational ASAS-COMOSPA study

  2019cites this paper
• The value of the Skåne Health-care Register: Prospectively collected individual-level data for population-based studies

  2019cites this paper
• A Pilot Study to Assess the Feasibility of a Web-Based Survey to Examine Patient-Reported Symptoms and Satisfaction in Patients with Ankylosing Spondylitis Receiving Secukinumab

  2019cites this paper
• Nonsteroidal Anti-inflammatory Drug use is Associated with Incident Hypertension in Ankylosing Spondylitis

  2019cites this paper
• Impact of ankylosing spondylitis on depression: a nationwide cohort study

  2019cites this paper
• Langfassung zur S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen, Update 2019

  2019cites this paper
• Cardiovascular morbidity and mortality in ankylosing spondylitis and psoriatic arthritis.

  2018cites this paper
• Prevalence and pattern of COMOrbidities in chronic Rheumatic and musculoskeletal Diseases: results of the COMORD study

  2018cites this paper
• Commentary: Evaluation of the Comorbidity Burden in Patients With Ankylosing Spondylitis Using a Large US Administrative Claims Data Set

  2018cites this paper
• Recommendations for the Management of Comorbidity in Patients With Axial Spondyloarthritis in Clinical Practice

  2018cites this paper
• Whole-Body Cryotherapy Decreases the Levels of Inflammatory, Oxidative Stress, and Atherosclerosis Plaque Markers in Male Patients with Active-Phase Ankylosing Spondylitis in the Absence of Classical Cardiovascular Risk Factors

  2018cites this paper
• Comorbidity, disability, and healthcare expenditure of ankylosing spondylitis in Korea: A population-based study

  2018cites this paper
• Vitamin D and Spondyloarthritis: Review of the Literature

  2018cites this paper
• Lifetime Risks of Valvular Heart Disease and Pacemaker Use in Patients With Ankylosing Spondylitis

  2018cites this paper
• Tumor Necrosis Factor Inhibitor Discontinuation in Patients with Ankylosing Spondylitis: An Observational Study From the US-Based Corrona Registry

  2018cites this paper
• Association of circulating calprotectin with lipid profile in axial spondyloarthritis

  2018cites this paper
• Association of ischemic stroke with ankylosing spondylitis: a nationwide longitudinal cohort study

  2018cites this paper
• Association of Acute Myocardial Infarction with ankylosing Spondylitis: A nationwide longitudinal cohort study.

  2018cites this paper
• Healthcare Utilization and Direct Costs in Patients with Ankylosing Spondylitis Using a Large US Administrative Claims Database

  2018cites this paper
• Evaluation of the comorbidity burden in patients with ankylosing spondylitis treated with tumour necrosis factor inhibitors using a large administrative claims data set

  2018cites this paper
• Evaluation of the comorbidity burden in patients with ankylosing spondylitis using a large US administrative claims data set

  2018cites this paper
• Ischemic heart disease and ankylosing spondylitis—assessing the role of inflammation

  2018cites this paper
• Recommendations by the Spanish Society of Rheumatology on the Use of Biological Therapies in Axial Spondyloarthritis

  2018cites this paper
• Perioperative Management of Patients with Inflammatory Rheumatic Diseases Undergoing Major Orthopaedic Surgery: A Practical Overview

  2018cites this paper
• Cardiovascular safety of non-steroidal anti-inflammatory drugs in chronic inflammatory rheumatic diseases.

  2018cites this paper